Korean J healthc assoc Infect Control Prev.  2018 Dec;23(2):53-62. 10.14192/kjhaicp.2018.23.2.53.

Infection Control at Hematopoietic Cell Transplantation Centers in Korea

• Park SM
• Jeong JS
• Kim MN
• Choi SH

• KMID: 2430269
• DOI: http://doi.org/10.14192/kjhaicp.2018.23.2.53

Abstract

BACKGROUND
The purpose of this study is to identify the current state of infection control practice at Hematopoietic Cell Transplantation (HCT) centers in Korea and to prepare effective standardized infection control guidelines.
METHODS
From September to October 2011, 32 HCT centers received questionnaires after consenting to participate in the study. The questionnaire consisted of 17 questions; six about general characteristics of HCT centers and 11 about infection control practices.
RESULTS
The response rate was 93.8% (30/32) while the HEPA filter performance in isolation room was 100 class (100%). Visitors were limited to one or two people in most centers. Protective clothing for healthcare personnel comprised sterile gowns, gloves and masks at around 50%. Daily bathing was the most common skin care practice (53.6%) in allogeneic HCT and 46.7% in autologous HCT in. Most of the oral gargling solutions (including normal saline, sodium bicarbonate solution, and chlorhexidine), supported tooth brushing. Peripheral and central venous catheter insertion and dressing replacement cycle were shorter than those of general patients. The disinfectant used for venous catheter insertion and dressing exchange used more betadine. Most of the patients' diets were sterile.
CONCLUSION
Infection control of the HCT centers in Korea varied from each center. Generally, there is no difference between allogeneic and autologous HCT in infection control practices, except in some detailed categories.

Keyword

Guideline; Hematopoietic Cell Transplantation; Infection Control; Infection

MeSH Terms

Bandages
Baths
Catheters
Cell Transplantation*
Central Venous Catheters
Delivery of Health Care
Diet
Humans
Infection Control*
Korea*
Masks
Povidone-Iodine
Protective Clothing
Skin Care
Sodium Bicarbonate
Tooth
Transplants*
Povidone-Iodine
Sodium Bicarbonate

Reference

1. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2006; 12:138–151.

2. Kim KS. 2009 Status of Hematopoietic Stem Cell Transplantation in Korea. J Korea Stem Cell Transplant Nurs Assoc. 2010; 12:9–12.

3. Yoo JH, Noh KT, Lee YS, Lee YH, Kwon HC, Kim JS, et al. Infectious complications during neutropenic period before and after hematopoietic stem cell transplantation -based on central venous catheter related septicemia. Korean J Hematop Stem Cell Transplant. 2002; 7:80–85.

4. Fenelon LE. Protective isolation: who needs it. J Hosp Infect. 1995; 30:Suppl. 218–222.

5. Krüger WH, Hornung RJ, Hertenstein B, Kern WV, Kröger N, Ljungman P, et al. Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation. J Hematother Stem Cell Res. 2001; 10:895–903.

6. Lee SJ, Astigarraga CC, Eapen M, Artz AS, Davies SM, Champlin R, et al. Variation in supportive care practices in hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008; 14:1231–1238.

7. Bevans M, Tierney DK, Bruch C, Burgunder M, Castro K, Ford R, et al. Hematopoietic stem cell transplantation nursing: a practice variation study. Oncol Nurs Forum. 2009; 36:E317–E325.

8. Yokoe D, Casper C, Dubberke E, Lee G, Muñoz P, Palmore T, et al. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated. Bone Marrow Transplant. 2009; 44:495–507.

9. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. Updated on 2011. https://www.cdc.gov/hai/pdfs/bsi-guidelines-2011.pdf.